Henshaw Capital’s AbbVie ABBV Stock Holding History

Henshaw Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,475	Closed	-$538K	–	161
2026 Q1	$538K	Hold	2,475	–	–	0.02%	151
2025 Q4	$566K	Hold	2,475	–	–	0.02%	150
2025 Q3	$573K	Hold	2,475	–	–	0.02%	161
2025 Q2	$459K	Hold	2,475	–	–	0.02%	244
2025 Q1	$519K	Hold	2,475	–	–	0.02%	226
2024 Q4	$440K	Hold	2,475	–	–	0.02%	238
2024 Q3	$489K	Hold	2,475	–	–	0.02%	223
2024 Q2	$425K	Hold	2,475	–	–	0.02%	195
2024 Q1	$451K	Hold	2,475	–	–	0.02%	187
2023 Q4	$384K	Hold	2,475	–	–	0.02%	206
2023 Q3	$369K	Hold	2,475	–	–	0.02%	195
2023 Q2	$333K	Hold	2,475	–	–	0.02%	166
2023 Q1	$394K	Hold	2,475	–	–	0.02%	146
2022 Q4	$400K	Hold	2,475	–	–	0.03%	138
2022 Q3	$332K	Hold	2,475	–	–	0.02%	190
2022 Q2	$379K	Hold	2,475	–	–	0.03%	176
2022 Q1	$401K	Hold	2,475	–	–	0.02%	193
2021 Q4	$335K	Buy	2,475 +475	+24%	+$56.1K	0.02%	236
2021 Q3	$216K	Hold	2,000	–	–	0.01%	310
2021 Q2	$225K	Hold	2,000	–	–	0.01%	330
2021 Q1	$216K	Hold	2,000	–	–	0.01%	325
2020 Q4	$214K	Sell	2,000 -44,550	-96%	-$4.28M	0.02%	322
2020 Q3	$4.08M	Buy	46,550 +44,000	+1,725%	+$4.14M	0.32%	45
2020 Q2	$250K	Buy	+2,550	New	+$225K	0.02%	248
2020 Q1	–	Sell	-2,550	Closed	-$226K	–	282
2019 Q4	$226K	Buy	+2,550	New	+$212K	0.02%	247

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Henshaw Capital's ABBV Position: Q2 2026 in Review

Henshaw Capital sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 2,475 shares — an estimated $538K sold.

Henshaw Capital first reported a position in ABBV in Q4 2019 and held it in 25 quarters. The position peaked at $4.08M in Q3 2020. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Henshaw Capital reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Henshaw Capital sold 2,475 AbbVie shares in Q2 2026, an estimated $538K.
Henshaw Capital first reported a position in AbbVie in Q4 2019 and held it in 25 quarters.
Henshaw Capital's AbbVie position peaked at $4.08M in Q3 2020.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Henshaw Capital's 13F filing for Q2 2026, filed 12 Aug 2026.